Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 491 results found. Search for [ trials human for coronavirus ]

Results 1 to 21 of 491
BusinessToday.In
May 11, 2021
Claims linking 5G technology with COVID-19 pandemic are false and have no scientific basis, says the Centre. Testing of 5G network has not even started anywhere in India


Associated Press
May 9, 2021
The Covid-19 vaccine cannot be inhaled via shedding and can only enter the human body through an administered dose


BusinessToday.In
May 4, 2021
Serum Institute of India (SII), which is known globally for its vaccine production capacity is among 20 Indian companies across sectors (healthcare, biotech and software services) to announce massive investment plans in the UK


PB Jayakumar
April 26, 2021
World Health Organisation (WHO)'s data on 'Landscape of candidate vaccines in clinical development' says a total of 91 vaccine candidates have reached the clinical development stage


Rashi Bisaria
New Delhi, April 22, 2021
New COVID-19 mutant in Bengal, escapes antibodies' immunity Scientists have found a new lineage of the SARS-CoV-2 virus named 'B.1.618' in India, which is predominantly circulating in West Bengal. This is the second lineage to be identified from the country. The infection through this variant makes plasma therapy as redundant as an investigational treatment. 600% jump in oxygen demand from hospitals Putting tremendous pressure on the nation's medical infrastructure, the latest surge in ...


BusinessToday.In
April 19, 2021
Jubilant Pharma says oral formulation is an affordable, more convenient, easy-to-administer and potentially effective treatment option for COVID-19 patients


BusinessToday.In
April 19, 2021
For this trial, the researchers are looking for 64 previously infected Covid-19 individuals between the age group 18 -30 years. The volunteers will be first reinfected with the original strain from ,China and will be monitored for a year


BusinessToday.In
April 13, 2021
India is the leading production hub for Sputnik V. RDIF has signed pacts with Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma, Virchow Biotech to produce over 850 million doses per year


BusinessToday.In
April 9, 2021
The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study.


Joe C Mathew
March 22, 2021
Virchow is the fifth Indian company to have an agreement with RDIF on Sputnik V. Dr Reddy's Laboratories was the first to announce a tie-up with RDIF to conduct the bridge studies (clinical trials) of Sputnik V vaccine


BusinessToday.In
March 16, 2021
Share of Gland Pharma touched an all-time high of Rs 2,784.45, rising 9.54% against previous close of Rs 2,541 on BSE


BusinessToday.In
March 16, 2021
COVID-19 vaccine: Gland Pharma said that the production of Sputnik V is expected to commence from third quarter of 2021 for estimated delivery starting from fourth quarter of 2021


Reuters
March 16, 2021
The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the shot in the United States


BusinessToday.In
March 10, 2021
Deal was signed last week. Apart from India, SII is providing Covishield to several poor nations through COVAX facility being led by Gavi, Vaccine Alliance, World Health Organisation, Coalition for Epidemic Preparedness Innovations, and others


Associated Press
March 8, 2021
On Sunday, travelers stepped up to an iris scanner after checking in, gave it a good look and breezed through passport control within seconds


BusinessToday.In
March 2, 2021
As senior citizens across the country take part in the vaccination drive, here is all the information they need two know about the two vaccines - Covaxin and Covishield


BusinessToday.In
February 20, 2021
Russia has already approved two COVID-19 vaccines, Sputnik V and EpiVacCorona, which were also granted approval before seeing any late-stage trial results


Reuters
February 18, 2021
Pfizer and BioNTech said they were doing similar lab work to understand whether their vaccine is effective against another variant first found in Brazil


BusinessToday.In
February 15, 2021
Earlier, Dr Reddy's had said it expects to roll out Sputnik V vaccine in India in March via Emergency Use Authorisation (EUA) after the completion of Phase 3 trials.


BusinessToday.In
February 3, 2021
Earlier, The Lancet had stated that Russia's experimental COVID-19 vaccine Sputnik V is 91.6 per cent affective against coronavirus infection. These results are based on Phase 3 trials of the vaccine in which 20,000 people had participated


PAGES 1 OF 25  12345